JPS6222992B2 - - Google Patents
Info
- Publication number
- JPS6222992B2 JPS6222992B2 JP56095418A JP9541881A JPS6222992B2 JP S6222992 B2 JPS6222992 B2 JP S6222992B2 JP 56095418 A JP56095418 A JP 56095418A JP 9541881 A JP9541881 A JP 9541881A JP S6222992 B2 JPS6222992 B2 JP S6222992B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- pyridyl
- cyclopropyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 60
- 150000003839 salts Chemical class 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 16
- 125000004076 pyridyl group Chemical group 0.000 claims description 15
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 7
- YNYQZWOWYAQXDE-UHFFFAOYSA-N 2-cyclopropylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1CC1 YNYQZWOWYAQXDE-UHFFFAOYSA-N 0.000 claims description 7
- -1 2-dimethylaminoethanol ester Chemical class 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims description 4
- 229940013085 2-diethylaminoethanol Drugs 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 159000000000 sodium salts Chemical group 0.000 claims description 3
- 238000005888 cyclopropanation reaction Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000000043 antiallergic agent Substances 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 230000003266 anti-allergic effect Effects 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000004617 chromonyl group Chemical group O1C(=CC(C2=CC=CC=C12)=O)* 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004997 halocarbonyl group Chemical group 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- SAIKULLUBZKPDA-UHFFFAOYSA-N Bis(2-ethylhexyl) amine Chemical compound CCCCC(CC)CNCC(CC)CCCC SAIKULLUBZKPDA-UHFFFAOYSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ã眮æïŒâã·ã¯ããããã«âã¯ãã¢
ã³ããã®è£œé æ³ãªãã³ã«è©²ã¯ãã¢ã³ãå«æãã補
è¬åŠççµæç©ã«é¢ããã æ¬çºæã®ååç©ã¯æ¬¡ã®åŒïŒïŒã§ç€ºãããïŒ ïŒ»åŒäžãR1ã¯æ°ŽçŽ ååã§ãããåã¯ãåŒãåº ïŒããã§R4åã³R5ã¯ããããç¬ç«ã«C1âC4ã¢ã«ã
ã«åºã§ããïŒã«ãã€ãŠçœ®æããããåã¯çœ®æãã
ãŠããªãC1âC6âã¢ã«ãã«åºã§ãããR2ã¯C1â
C4ã¢ã«ãã«åºã§ãããR3ã¯ããªãžã«åºåã¯ã¡ã
ã«åºã«ãã€ãŠçœ®æãããããªãžã«åºãè¡šããã æ¬çºæã®ç®çç©ã¯ã補è¬åŠçã«èªå®¹æ§ã®åŒ
ïŒïŒã®ååç©ã®å¡©ã§ããããªãã³ã«å šãŠã®èã
ããããç°æ§äœåã³ãã®æ··åç©ã§ãããã æ¬çºæã®ååç©ã¯ãã·ã¹âã§ããã©ã³ã¹âç«äœ
é 眮ã§ããããαåã³Î²ççŽ ååäžã®ïŒåã®æ°ŽçŽ
ååãã·ã¯ããããã³ç°é¢ã«å¯ŸããŠåãåŽã®äžã«
ããå Žåã該ååç©ã¯ã·ã¹âç«äœé 眮ã§ãããã
ã®éããŸãåãã§ããããŸããã·ã¹âãšãã©ã³ã¹
âç°æ§äœãšã®æ··åç©ããæ¬çºæã®ç¯å²ã«å±ããã
æå©ã«ãæ¬çºæã®ååç©ã¯ããã©ã³ã¹âç«äœé 眮
ã§ããã R3åºäžã®çœ®æåºã®äœçœ®ã確èªããããã«ä»ã
ããçªå·ã¯ã次ã«ç€ºãããã«åžžçšã®ãã®ã§ããïŒ ã¢ã«ãã«åºãã¢ã«ã±ãã«åºãã¢ã«ã³ãã·åºåã³
ã¢ã«ã«ãã€ã«ãªãã·åºã¯ãåæéåã¯çŽéã®åºã§
ãã€ãŠããã R1ã¯çœ®æãããŠããªãC1âC6ã¢ã«ãã«åºãæ
å©ã§ãããç¹ã«ã¡ãã«åºããšãã«åºãã€ãœããã
ã«åºãïœâããã«åºåã³ããã·ã«åºã§ããã R4åã³ïŒåã¯R5ã¯æå©ã«C1ãC4ã¢ã«ãã«åºã
ç¹ã«ã¡ãã«åºããšãã«åºãã€ãœãããã«åºåã³ïœ
âããã«åºã§ããã ããããã
R2ã¯æå©ã«C2ãC3ã¢ã«ãã«åºãç¹ã«ãšãã«åº
åã³ãããã«åºã§ããããåã¯C3ã¢ã«ã±ãã«
åºãç¹ã«ã¢ãªã«åºã§ããã R3ãããªãžã«åºã§ããå ŽåãïŒâããªãžã«åº
ãæå©ã§ããã 補è¬åŠçã«èªå®¹æ§ã®å¡©ã®äŸã¯ãæ°Žé žåâãããª
ãŠã ãâã«ãªãŠã ãâã«ã«ã·ãŠã åã³âã¢ã«ãããŠ
ã ã®ãããªç¡æ©å¡©åºãšã®å¡©ã§ãã€ãŠããããããª
ãžã³ãããªãšãã«ã¢ãã³ãããªãšã¿ããŒã«ã¢ã
ã³ããžãã³ãžã«ã¢ãã³ãã¡ãã«ãã³ãžã«ã¢ãã³ã
ãžâïŒïŒâãšãã«âããã·ã«ïŒâã¢ãã³ããããªãž
ã³ãâãšãã«ãããªãžã³ãã»ïŒ®âãžãšãã«ã¢
ãããšãã«ã¢ãã³ãâãšãã«ã¢ã«ããªã³ãβâ
ããšããã«ã¢ãã³ãâãã³ãžã«âβâããšãã
ã«ã¢ãã³ãâãã³ãžã«âã»ïŒ®âãžã¡ãã«ã¢ã
ã³åã³ä»ã®èªå®¹æ§ææ©ã¢ãã³ã®ãããªææ©å¡©åºãš
ã®å¡©ããªãã³ã«ç¡æ©é žãäŸãã°å¡©åæ°ŽçŽ é žãèå
æ°ŽçŽ é žåã³ç¡«é žãªãã³ã«ææ©é žãäŸãã°ã¯ãšã³
é žãé ç³é žããã¬ã€ã³é žããªã³ãŽé žãããã«é žã
ã¡ã¿ã³ã¹ã«ãã³é žåã³ãšã¿ã³ã¹ã«ãã³é žãšã®å¡©ã§
ãã€ãŠãããã æå©ãªå¡©ã¯ããããªãŠã å¡©åã³ã«ãªãŠã å¡©ããª
ãã³ã«å¡©åºæ§ãšã¹ãã«ã®ãäŸãã°ãžãšãã«ã¢ãã
ãšãã«ãšã¹ãã«åã³ãžã¡ãã«ã¢ãããšãã«ãšã¹ã
ã«ã®ãããªãŠã å¡©ãã«ãªãŠã å¡©ã䞊ã³ã«å¡©é žå¡©ã§
ããã ç¹ã«ããããæ¬çºæã®ååç©ã¯ãåŒïŒïŒã®å
åç©ããã®å ŽåR1ã¯(a)æ°ŽçŽ ååã
ãåŒãåºãäœããR4åã³R5ã¯ãããã åäžããåã¯ç°ãªããC1ãC4ã¢ã«ãã«åºã§ã
ãïŒã«ãã€ãŠçœ®æãããããåã¯çœ®æãããŠããª
ãC1ãC6ã¢ã«ãã«åºã§ãããR2ã¯C1ãC4ã¢ã«ã
ã«åºãç¹ã«ãšãã«åºåã¯ãããã«åºã§ããããã
ããã¯C3âã¢ã«ã±ãã«åºãç¹ã«ã¢ãªã«åºã§ã
ããR3ã¯ïŒâããªãžã«åºã§ãããããããã¯ã¡
ãã«åºã«ãã€ãŠçœ®æãããïŒâããªãžã«åºã§ã
ããããªãã³ã«ãã®è£œè¬åŠçã«èªå®¹æ§ã®å¡©ã§ã
ãã æ¬çºæã®ããããååç©ã«ãããŠãâCOOR1åº
ã¯æå©ã«éé¢ã®åã¯å¡©ã«ãããã«ã«ããã·åºã§ã
ãã ç¹ã«ããããæ¬çºæã®ååç©ã®äŸã¯æ¬¡ã®ãã®ã§
ããïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãšãã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãããã®å¡©ãç¹ã«å¡©
åºæ§ãšã¹ãã«ïŒäŸãã°ïŒâãžãšãã«ã¢ãããšã¿ã
ãŒã«åã³ïŒâãžã¡ãã«ã¢ãããšã¿ããŒã«ãæãã
該ãšã¹ãã«ïŒãªãã³ã«ãã®C1ãC6ã¢ã«ãã«ãšã¹
ãã«ãç¹ã«ã¡ãã«ãšã¹ãã«ããšãã«ãšã¹ãã«ãã€
ãœãããã«ãšã¹ãã«ãïœâããã«ãšã¹ãã«åã³ã
ãã·ã«ãšã¹ãã«ã®ãããªãŠã å¡©åã¯å¡©é žå¡©ã æ¬çºæã®ååç©ã¯ã次ã®æ¹æ³ã«ãã€ãŠè£œé ãã
ãïŒ åŒïŒïŒïŒ ãåŒäžãR1ãR2åã³R3ã¯åèšã®ãã®ãè¡šãããã®
ååç©åã¯ãã®å¡©ãã·ã¯ããããã³åããå¿ èŠã«
å¿ããŠãåŒïŒïŒã®ååç©ãå ¬ç¥æ¹æ³ã«ãã€ãŠå
æ°Žå解åã¯ãšã¹ãã«åãããã€ïŒåã¯å¿ èŠã«å¿ã
ãŠãåŒïŒïŒã®ååç©ã補è¬åŠçã«èªå®¹æ§ã®å¡©ã«
å€æãããã€ïŒåã¯å¿ èŠã«å¿ããŠãå¡©ãéé¢åå
ç©ã«å€æããã€ïŒåã¯å¿ èŠã«å¿ããŠãç°æ§äœæ··å
ç©ãåé¢ããŠåç°æ§äœã«ããã åŒïŒïŒã®ååç©ã®ã·ã¯ããããã³åã¯ãæå©
ã«ãåŒïŒïŒã®ååç©ããžã¡ãã«ã¹ã«ãããœããŠ
ã ã¡ããªãïŒäŸãã°J.Chem.Soc.ã1967幎ã第
2495é ã«èšèŒãããŠããæ¹æ³ã«ãã€ãŠè£œé ïŒãšå
å¿ãããäŸãã°ãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«
ããããã
ã¹ã«ããã·ãããžãªããµã³åã³ãããã®æ··åç©ã
ãæã矀ããéžæãããäžæŽ»æ§ææ©æº¶å€äžã§ãæ
å©ã«çŽïŒâãçŽ50âã®ç¯å²å ã®æž©åºŠã§åŠçããã
ãšã«ãã€ãŠå®æœããããšãã§ããã åŒïŒïŒã®ååç©ã¯äžèšã®ããã«ãå ¬ç¥æ¹æ³ã«
ãã€ãŠãåŒïŒïŒã®ä»ã®ååç©ã«å€æããããšã
ã§ãïŒäŸãã°ãåŒïŒïŒã®ååç©ïŒããã§ãâ
COOR1åºã¯ãšã¹ãã«åãããã«ã«ããã·åºã§ã
ãïŒã¯ãå æ°Žå解äŸãã°æ°Žåã¯äœçŽèèªæã¢ã«ã³
ãŒã«ã®ãããªæº¶å€äžã®äŸãã°æ°Žé žåãããªãŠã å
ã¯æ°Žé žåã«ãªãŠã ã䜿çšãã宀枩çŽ150âã®ç¯å²
å ã®æž©åºŠã§åŠçããå¡©åºæ§å æ°Žå解ãã«ãã€ãŠåŒ
ïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åºã¯ã«ã«ã
ãã·åºã§ããïŒã«å€æããããšãã§ããåãåå¿
ã¯ãäŸãã°50âããé«ã枩床ã§ããžã¡ãã«ãã«ã
ã¢ããäžã®èåãªããŠã ãçšããåŠçã«ãã€ãŠå®
æœããããšãã§ããã ç¹ã«ãåŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1
åºã¯ïœâãããã·ã«ã«ããã«åºã§ããïŒã¯ãäŸã
ã°æº¶å€ã®äžåšäžã«ããããã¯äŸãã°ãã³ãŒã³ãã
ã«ãšã³ããžãªããµã³ãããªã矀ããéžæãããäž
掻æ§ææ©æº¶å€ã®ååšäžã«ãçŽïŒâãçŽ50âã®ç¯å²
å ã®æž©åºŠã§ãããªãã«ãªã«é ¢é žãçšããåŠçã«ã
ã€ãŠãåŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åº
ã¯ã«ã«ããã·åºã§ããïŒã«å€æããããšãã§ãã
ãããã¯äŸãã°ïŒãžã€ãŒãã«ã»ãªãã»ãŒã»ã¢ã¡ãª
ã«ã³ã»ã±ãã«ã«ã»ãœãµã€ãšãã€âïŒJ.Am.Chem.
Soc.ïŒâ第99å·»ã第968é ã1977幎ã«èšèŒãããŠã
ãæ¹æ³ã«ãã€ãŠäžæŽ»æ§ææ©æº¶å€ãæå©ã«ããã©ã¯
ãã«ã¡ã¿ã³äžã®ããªã¡ãã«ãšãŒãã€ããçšããåŠ
çã«ãã€ãŠå€æããããšãã§ããã åŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åºã¯ã«
ã«ããã·åºã§ããïŒã¯ãåžžæ³ã«ãã€ãŠãäŸãã°é ž
ã®ã¢ã«ã«ãªå¡©ãé©åœãªã¢ã«ãã«ããã²ã³åç©ãšã
äŸãã°ã¢ã»ãã³ããžãªããµã³ããžã¡ãã«ãã«ã ã¢
ããããããµã¡ãã«ãã¹ãã¹ããªã¢ããã®ãããª
äžæŽ»æ§æº¶å€äžã§çŽïŒâãçŽ100âã®ç¯å²å ã®æž©åºŠ
ã§åå¿ãããããšã«ãã€ãŠåŒïŒïŒã®ååç©ãã
ã®å ŽåãâCOOR1åºã¯ãšã¹ãã«åãããã«ã«ãã
ã·åºãäŸãã°ãåŒãåºïŒäœããR4åã³R5㯠åèšã®ãã®ãè¡šããïŒã«ãã€ãŠçœ®æãããããå
ã¯çœ®æãããŠããªãã«ã«ãã¢ã«ã³ãã·åºã§ããã
ã«å€æããããšãã§ããã ãŸããåŒïŒïŒã®ååç©ã®ãšã¹ãã«åã¯ã(a)äŸ
ãã°æº¶å€ã®äžåšäžãããã¯äŸãã°ãã³ãŒã³ããã«
ãšã³ããã·ã¬ã³ããžãªããµã³ããžã¯ãã«ãšã¿ã³ã
å¡©åã¡ãã¬ã³ãããã©ããããã©ã³ã®ãããªäžæŽ»
æ§ææ©æº¶å€äžã§æå©ã«çŽïŒâãçŽ120âã®ç¯å²å
ã®æž©åºŠã§ãææã®é žããã²ã³åç©ãäŸãã°å¡©åãª
ããµãªã«ãå¡©åããªãã«ãPCl3ãPCl5åã¯POCl3
ãšåå¿ãããããšã«ãã€ãŠãåŒïŒïŒã®ååç©
ïŒãã®å ŽåãâCOOR1åºã¯ã«ã«ããã·åºã§ããïŒ
ãçžå¿ããããã«ã«ããã«ãæå©ã«ã¯ãã«ã«ã«ã
ãã«ãèªå°äœã«å€ãïŒæ¬¡ã«(b)åŸãããããã«ã«ã
ãã«èªå°äœãé©åœãªåŒR1âOHã®ã¢ã«ã³ãŒã«ïŒã
ã®å ŽåãR1ã¯åèšã®ãã®ãè¡šããïŒãšãäŸãã°
ãã³ãŒã³ããã«ãšã³ããã·ã¬ã³ããžãªããµã³ããž
ã¯ãã«ãšã¿ã³ãå¡©åã¡ãã¬ã³ãããã©ããããã©
ã³ã®ãããªäžæŽ»æ§æº¶å€äžã§ãçŽïŒâãçŽ120âã®
ç¯å²å ã®æž©åºŠã§ãæå©ã«äŸãã°ããªãšãã«ã¢ãã³
åã¯ãžãšãã«ã¢ãã³ã®ãããªå¡©åºã®ååšäžã«åå¿
ãããŠå®æœããããšãã§ããã ãŸããåŒïŒïŒã®ååç©ã®å Žåã«ããé å¡©ãªã
ã³ã«å¡©ã®éé¢ååç©ãžã®å€æåã³ç°æ§äœæ··åç©ã®
åç°æ§äœãžã®åé¢ã¯ãåžžæ³ã«ãã€ãŠå®æœããããš
ãã§ããã äŸãã°ãå Žåã«ãã察æäœã®å察æäœãžã®åé¢
ã¯ãå Žåã«ãã掻æ§å¡©åºãçšããé å¡©åã³åŒç¶ã
åå¥çµæ¶ã«ãã€ãŠå®æœããããšãã§ãããããªã
ã¡ãã·ã¹âåã³ãã©ã³ã¹â幟äœåŠçç°æ§äœæ··åç©
ã®åé¢ã¯ãäŸãã°åå¥çµæ¶ã«ãã€ãŠå®æœããããš
ãã§ããã åŒïŒïŒã®ååç©ã¯ãäŸãã°ãã«ã®ãŒç¹èš±æ现
æžç¬¬855657å·ã«çžå¿ãã西ãã€ãåœç¹èš±åºé¡å ¬é
第P2725932å·æ现æžã«èšèŒãããæ¹æ³ã«ãã€ãŠ
補é ããããšãã§ããã æ¬çºæã®ååç©ã¯æã¢ã¬ã«ã®ãŒäœçšãæããã
ãšãèªãããããããã€ãŠã¢ã¬ã«ã®ãŒæºã®å šãŠã®
çŸç ãäŸãã°æ°ç®¡æ¯åæ¯ãã¢ã¬ã«ã®ãŒæ§éŒ»çãæ¯
èç±ãè麻ç¹åã³ç®èç ã®äºé²åã³æ²»çã«æå¹ã§
ããã æ¬çºæã®ååç©ã®æã¢ã¬ã«ã®ãŒäœçšã¯ãäŸãã°
該ååç©ãã°ãŒã¹ïŒGooseïŒJ.åã³ãã¬ã¢
ïŒBlairïŒA.M.J.NïŒImmunologyã第16å·»ã第749
é ã1969幎ïŒã«ããããºãã®ååç®èéææ§çŸè±¡
ïŒPCAïŒè©Šéšã«ãããŠæå¹ã§ããäºå®ã«ãã€ãŠæ
ããããã
ããã§ããã æ¬çºæã®ååç©ã®éèŠãªç¹æ§ã¯ã該ååç©ãçµ
å£æäžã®å Žåã«ã¯æã¢ã¬ã«ã®ãŒäœçšã®é«ãå¹³åã
瀺ãããšã§ããã 次衚ã¯ãããºãã®PCAè©Šéšã«ãããå ¬ç¥ã®æ
ã¢ã¬ã«ã®ãŒæ§å»è¬ãžãããªãŠã ã¯ãã¢ã°ãªã±ãŒã
ïŒDSCGïŒãšæ¯èŒããŠãã©ã³ã¹ïŒâã«ã«ããã·â
ïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããª
ãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ïŒK13804ïŒã
ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ïŒœâã¯ãã¢
ã³ïŒFCE20251ïŒããã©ã³ã¹ïŒâã«ã«ããã·âïŒ
âãšãã«âïŒâïŒâïŒ6â²âã¡ãã«â2â²âããªãž
ã«ïŒâã·ã¯ããããã«ïŒœâã¯ãã¢ã³
ïŒFCE20250ïŒããã©ã³ã¹ïŒâã«ã«ããã·âïŒâã
ããã«âïŒâïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒ
âã·ã¯ããããã«ïŒœã¯ãã¢ã³ïŒFCE20417ïŒãã
ã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâïŒ
âïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ïŒœâã¯ãã¢ã³ïŒFCE20501ïŒãçµå£æäžããåŸ
ã«åŸãããäœçšå€ã瀺ãã äœçšããŒã¿ã¯ãæäœã«äœ¿çšãããè¡æž ã®æŽ»éã
ååãŸã§æžå°ãããããšã®ã§ãã掻æ§ååç©ã®é©
çšéãšããŠå®çŸ©ãããèšå·ïŒ«Bã§è¡šããããïŒ ïŒ«BïŒïŒ¢ïŒïŒ€ïŒ²âïŒ åŒäžã ïŒmgïŒKgã§è¡šããããæ®æäœçšååç©ã®é©çš
éïŒ DRïŒé©çšéæ¯çïŒæ®æç©è³ªãçšããè¡æž ã®é©çš
éå¹æ察æ°é¢æ°ãšæ®æç©è³ªãçšããªã該é¢ä¿ãš
ã®å·®ã®é察æ°ïŒJ.H.Gaddumä»ãExp.Physiol.
ã1955幎ã第40å·»ã第49é åç §ïŒã ããã§ãBãéžæãããããããšããã®ãã
ã®å€ã¯ç¬ç«ããŠè¬å€é©çšéåã³æäœã«äœ¿çšããã
ã¬ã¢ã®ã³æ¿åºŠã®åæ¹ã«ç¡é¢ä¿ã§ããããã§ããã Bå€ãäœããã°äœãã»ã©ãæã¢ã¬ã«ã®ãŒäœçš
ã¯äžå±€é«ããªãã ãè¡šã ãè¡šã æã¢ã¬ã«ã®ãŒäœçšã¯ãã¢ã¿ïŒMotaïŒïŒ©ãâã€ã
ãŠããžãŒïŒImmunologyïŒâã第ïŒå·»ã第681é ã
1964幎ã®æ¹æ³ã«åŸããããºãã«ãããŠå¢å€§ããã
å皮现è芪åæ§æäœã䜿çšããŠã°ãŒã¹ïŒGooseïŒ
J.åã³ãã¬ã¢ïŒBlairïŒA.M.J.NïŒäžèšåŒçšæäžïŒ
ã«ããlgEâéæ¥PCAã®æå¶ã«ãã€ãŠæž¬å®ããã è©Šéšååç©ããæåé©çš15ååã«çµå£ïŒp.o.ïŒ
æäžãïŒå°ãªããšãïŒå¹ã®ããºããåæäžéã«å¯Ÿ
ããŠäœ¿çšããã çµå£æäžåŸïŒæ¥éã«ç€ºãããæ¥æ§æ¯æ§ã¯ãæ¬çº
æã®ååç©ã®æçšæ§ãè©äŸ¡ãããã®ã§ãã€ããäŸ
ãã°ããã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«
âïŒâãïŒâïŒ6â²âã¡ãã«2â²âããªãžã«ïŒâã·ã¯ã
ãããã«ãâã¯ãã¢ã³ã¯ãããºãã«ãããŠLD50ïŒ
400mgïŒKgã瀺ããã æŽã«ãæ¬çºæã®ååç©ã¯ãã¿ã«ã®ïŒTakagiïŒ
K.åã³ãªã«ãïŒOkabeïŒS.ã«ãã€ãŠèšèŒãããæ¹
æ³ïŒJap.J.of Pharmac.ã1968幎ã第19å·»ïŒç¬¬ïŒ
å·ïŒã®å€åœ¢ã«ãã25âã§40åé氎济äžã«ææãã
ããºãã®ã¹ãã¬ã¹èªçºæœ°çã®æå¶ã«äœçšããããš
ãå€æããäºå®ã«ãã€ãŠèšŒæããããããªæ朰ç
äœçšãæããã ãŸããæ¬çºæã®ååç©ã¯ããããã«ã³ããšãã
ïŒKanzettïŒåã³ã¬ã¹ã©ãŒïŒRosslerïŒãArch.Exp.
Path.Pharmakol.ã第71å·»ã第195é ã1940幎ã®
æ¹æ³ã«ããã¢ã«ã¢ããã®ãã¹ã¿ãã³ã«ãã€ãŠèªçº
ãããæ°ç®¡æ¯çæã®æå¶ã«äœçšããããšãå€æã
ãäºå®ã«ãã€ãŠç€ºãããããã«æ°ç®¡æ¯æ¡åŒµäœçšã
èªããããã æ¬çºæã®ååç©ã¯ãåžžæ³ã§ãäŸãã°çµå£çåã³
éçµå£çã«æå©ã«0.5ã15mgïŒKgã®ïŒæ¥éã§æçš
ããããšãã§ããããåã¯åžå ¥ã«ãã€ãŠæå©ã«äž
æ¥é0.5ã100mgãæå©ã«0.5ã25mgã®ïŒæ¥éã§æ
äžããããšãã§ããããåã¯å±æå¿çšã«ãã€ãŠã
äŸãã°ä¹³å€100mgãããæå¹æåçŽ0.5ãïŒmgãæ
å©ã«ïŒãïŒmgãæããä¹³å€ã§é©çšããããšãã§ã
ããããã
ãã å¿è«ã補è¬åŠçã«èªå®¹æ§ã®ãã€ãªã€ãŒåã¯åžé
å€ãšçµåããæ¬çºæã®ååç©ãæãã補è¬åŠççµ
æç©ã®æ§è³ªã¯ãææãããé©çšæ¹æ³ã«äŸåããã 該çµæç©ã¯ãåžžæ³ã§ãæ®éã®æåãçšããŠè£œé
ããããšãã§ãããäŸãã°ãæ¬çºæã®ååç©ã¯ã
æ°Žæ§åã¯æ²¹æ§æº¶æ¶²åã¯æžæ¿æ¶²ããšãŒããŸã«ããªã
ã³ã«ç²æ«ãé å€ãäžžå€ããŒã©ãã³ã«ãã»ã«ãã·ã
ãããç¹æ»Žå€ãåè¬åã¯ã¯ãªãŒã ããããã¯å±æ
çšããŒã·ãšã³ã®åœ¢ã§é©çšããããšãã§ããã åŸã€ãŠãçµå£æäžããããã®æ¬çºæã®ååç©ã
æãã補è¬åŠççµæç©ã¯ãæå©ã«ãäœçšç©è³ªãåž
éå€äŸãã°ä¹³ç³ãããã¹ãããŒã¹ãçœç³ããã³ã
ããŒã«ããœã«ãããŒã«ãã»ã«ããŒã¹ïŒæœ€æ»å€ãäŸ
ãã°ã·ãªã«ãã¿ã«ã¯ãã¹ãã¢ãªã³é žãã¹ãã¢ãªã³
é žãã°ãã·ãŠã åã¯ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãå
ã³ïŒåã¯ããªãšãã¬ã³ã°ãªã³ãŒã«ãšäžç·ã«å«æã
ãé å€ãäžžå€åã¯ãŒã©ãã³ã«ãã»ã«ã§ãããå
ã¯ã該çµæç©ã¯çµåå€äŸãã°æŸ±ç²ããŒã©ãã³ãã¡
ãã«ã»ã«ããŒã¹ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã
ã¢ã©ãã¢ãŽã ããã©ã¬ã«ã³ããããªããã«ãããª
ãã³ã厩å£å€äŸãã°æŸ±ç²ãã¢ã«ã®ã³é žãã¢ã«ã®ã³
é žå¡©ãã°ã«ã³ãŒã«é žãããªãŠã 柱ç²ïŒæ²žéš°æ§æ··å
ç©ïŒè²çŽ ïŒçå³æã湿最å€äŸãã°ã¬ã·ãã³ãããª
ãœã«ããŒããã©ãŠãªã«ã¹ã«ããšãŒãåã³äžè¬ã«è£œ
è¬åŠçé åã«äœ¿çšãããç¡å®³ã§ãã€è¬ç©åŠçåŠæ¹
ã«äœ¿çšãããäžæŽ»æ§ã®ç©è³ªãšå ±ã«ãå«æããŠããŠ
ããã該補å€ã¯ãå ¬ç¥æ¹æ³ã§ãäŸãã°æ··åãç²
ç ãã¿ãã¬ãããç ç³ã³ãŒãã€ã³ã°ãåã¯èã³ãŒ
ãã€ã³ã°ã«ãã€ãŠè£œé ããããšãã§ããã ã¢ã¬ã«ã®ãŒæ§åæ¯ã®æ²»çã®ããã«ãæ¬çºæã®å
åç©ã¯åžå ¥ã«ããé©çšãããããã®ãããªçšæ³ã®
ããã«ãé©åœãªçµæç©ããæå©ã«åžžçšã®åŽé§åšã«
ãã€ãŠæäžãããæ°Žäžã®ãããªãŠã å¡©ã®ãããªå¡©
ã®åœ¢ã®æå¹æåã®æžæ¿æ¶²åã¯æº¶æ¶²ãããªã€ãŠããŠ
ããããŸãã該çµæç©ã¯ãå å§å®¹åšãäŸãã°ãšã¢
ãŸãŒã«ãã€ã¹ãã³ãµãŒããæäžããããžã¯ãã«ãž
ãã«ãªã«ã¡ã¿ã³åã¯ãžã¯ãã«ããã©ãã«ãªã«ãšã¿
ã³ã®ãããªæ®éã®æ¶²äœåŽå°è¬äžã®æå¹æåã®æžæ¿
液åã¯æº¶æ¶²ãããªã€ãŠããŠããããè¬ç©ãåŽå°è¬
ã«æº¶è§£äžèœã§ããå Žåã«ã¯ããšã¿ããŒã«ããžãã
ãã¬ã³ã°ãªã³ãŒã«ãã€ãœãããã«ããªã¹ããŒãã®
ãããªè£å©æº¶å€ãªãã³ã«ïŒãããã¯è¬ç©ãåŽå°è¬
åªäœã«æžæ¿ãããããã«çé¢æŽ»æ§å€ã®çµæç©ãžã®
æ·»å ãå¿ èŠã§ãã€ãŠãããããã®ãããªçé¢æŽ»æ§
å€ã¯ã該ç®çã®ããã«æ®éã«äœ¿çšããããäŸãã°
éã€ãªã³çé掻æ§å€ãäŸãã°ã¬ã·ãã³ã§ãã€ãŠã
ãããæ¬çºæã®ååç©ã¯ãé©åœãªç©ºæ°åžå ¥åšã«ã
ã€ãŠç²æ«ã®åœ¢ã§æäžããããšãã§ãããã®å Žåæ
å¹æåã®åŸ®çŽ°ç²åç¶ç²æ«ã¯ãä¹³ç³ã®ãããªåžéç©
質ãšæ··åããããšãã§ããã æŽã«ãæ¬çºæã®ååç©ã¯ãåžžæ³ã§ç®å åã¯éè
å 泚å°ã«ãã€ãŠæäžããããšãã§ããã ãã®å çšã«å ããŠãæ¬çºæã®ååç©ã¯ãå±æé©
çšã®çµæç©ãäŸãã°ç®èç§åŠçæ²»çã«äœ¿çšããã
ã¯ãªãŒã ãããŒã·ãšã³åã¯ããŒã¹ããšããŠäœ¿çšã
ãããšãã§ããããã®çµæç©ã«å¯ŸããŠãæå¹æå
ã¯åžžçšã®æ²¹æ§åã¯ä¹³å賊圢å€ãšæ··åããããšãã§
ããã æ¬çºæã次ã®å®æœäŸã«ãã€ãŠè©³èª¬ãããããã®
å®æœäŸã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãã äŸ ïŒ ããªã¡ãã«âã¹ã«ãããœããŠã ãšãŒãã€ã
ïŒ2.86ïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ30mlïŒäžã®
50ïŒ æ°ŽçŽ åãããªãŠã ïŒ0.62ïœïŒãšæ¹æäžã«å®€æž©
ã§ïŒæéåå¿ããã次ã«ãžã¡ãã«ãã«ã ã¢ãã
ïŒ30mlïŒäžã®ãã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒ
âãããã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâãã
ã«ãâã¯ãã¢ã³ïŒ3.59ïœïŒã®æº¶æ¶²ãå ããã該混
åç©ãæ¹æäžã«å®€æž©ã§90åéåå¿ããã次ã«æ°·æ°Ž
ã§åžéããé ¢é žãšãã«ã§æœåºãïŒææ©çžãïŒïŒ
NaHCO3åã³æ°Žã§äžæ§ã«ãªããŸã§æŽæµãããç空
äžã§èžçºä¹Ÿåºãããã¡ã¿ããŒã«ããæ¶åºããã
ãšããã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒâããã
ã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ãâã¯ãã¢ã³ïŒ2.3ïœèç¹180âã182âïŒãåŸã
ãããããããã95ïŒ ãšã¿ããŒã«æº¶æ¶²ïŒ40mlïŒäž
ã®ïŒïŒ KOHãšéæµæž©åºŠã§30åéåå¿ããããå·
åŽåŸã«ã該åå¿æ··åç©ã10ïŒ NaH2PO4ã§é žæ§ã«
ããç空äžã§æ¿çž®ããæ°Žã§åžéãïŒæ²æ®¿ç©ãå¥
ããæ°Žã§æŽæµãããã€ãœãããããŒã«ããæ¶åºã
ãããšãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«
âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâ
ã¯ãã¢ã³ïŒ1.5ïœïŒãåŸãããã äŸ ïŒ äŸïŒã«åŸã€ãŠå®æœãã次ã®ååç©ã補é ããïŒ
ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâã¡ãã«âïŒâ
ãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢
ããããã
ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâããã«âïŒâ
ãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢
ã³ã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒïŒïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ70mlïŒäž
ã®æ²åã¡ãã«ïŒ5.2ïœïŒåã³ç¡æ°ŽK2CO3ïŒ6.3ïœïŒ
ãšã宀枩ã§ïŒæéæ¹æäžã«åå¿ããããæ°·æ°Žã§çš
éã®åŸã«ãæ²æ®¿ãéããã€ãœãããã«ãšãŒãã«
ããæ¶åºãããããã©ã³ã¹âïŒâã«ã«ããã·âïŒ
âãããã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ã
ãããã«ãâã¯ãã¢ã³ã¡ãã«ãšã¹ãã«ïŒ6.1ïœïŒ
ïŒèç¹180ã182âïŒãåŸãããã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒ3.0ïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ40mlïŒ
äžã®ïŒâã¯ãã«âïŒâãžãšãã«ã¢ããâãšã¿ã³
ïŒ2.7ïœïŒåã³ç¡æ°ŽK2CO3ïŒ2.8ïœïŒãšãæ¹æäžã«
20âã§ïŒæéåå¿ããããæ°Žã§çšéã®åŸã«ãæ²æ®¿
ãéããäžæ§ã«ãªããŸã§æ°Žã§æŽæµããã€ãœãã
ãã«ãšãŒãã«ããæ¶åºããããšããã©ã³ã¹âïŒâ
ã«ã«ããã·âïŒâãããã«âïŒâãïŒâïŒ2â²âããª
ãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ïŒâãžãšãã«
ã¢ãããšãã«ãšã¹ãã«ïŒ1.8ïœïŒãåŸãããã äŸ ïŒ ããªã¡ãã«ã¹ã«ãããœããŠã ãšãŒãžãïŒ3.46
ïœïŒãšãžã¡ãã«ãã«ã ã¢ããïŒ50mlïŒäžã®50ïŒ æ°Ž
çŽ åãããªãŠã ïŒ0.76ïœïŒãšããæ¹æäžã«å®€æž©ã§
ïŒæéåå¿ããã次ã«ãžã¡ãã«ãã«ã ã¢ããïŒ50
mlïŒäžã®ãã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒâã
ããã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒ
âãšããã«ãâã¯ãã¢ã³ãèç¹161âã164âã
ïŒ3.8ïœïŒã®æº¶æ¶²ãæ·»å ããã該混åç©ãæ¹æäžã«
宀枩ã§ïŒæéåå¿ããã次ã«ãããæ°·æ°Žã§çšéã
ããæ²æ®¿ç©ãé ¢é žãšãã«ã§æœåºãã溶液ãç空äž
ã§èžçºä¹Ÿæ¶žãããããããŠåŸããããã©ã³ã¹âïŒ
âã«ã«ãã¡ããã·âïŒâãããã«âïŒâãïŒâ
ïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããããã«ã
âã¯ãã¢ã³ïŒ3.9ïœïŒã95ïŒ ãšã¿ããŒã«æº¶æ¶²
ïŒ67.6mlïŒäžã®ïŒïŒ KOHãšéæµæž©åºŠã§10åéåå¿
ããããå·åŽåŸã該åå¿æ··åç©ãæ°·æ°Žã§çšéãã
ã€NaHPO4ã§äžåããæ²æ®¿ç©ãéããã€äžåã
ãããŸã§æ°Žã§æŽæµãããïŒâãã¿ãã³ããæ¶åºã
ãããšããã©ã³ã¹âïŒâã«ã«ããã·âïŒâããã
ã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·
ã¯ããããã«ãâã¯ãã¢ã³1.4ïœãåŸããããèç¹
216âã217âïŒ I.R.ïŒKBrïŒïŒÎœïŒïŒ£ïŒïŒ¯ïŒé ž1710cm-1 ÎœïŒïŒ£ïŒïŒ¯ïŒã¯ãã¢ã³1640ã1620cm-1 N.M.R.ïŒDMSOâd6ïŒÎŽïŒ0.82ïŒïœïŒïŒâCH2CH2
CH ïŒïŒ 1.44ïŒïœïŒïŒâCH2 CH 2CH3ïŒ 1.85ïŒïœïŒãåŒã 2.47ïŒïœïŒïŒâCH3ïŒ 2.40ã3.04ïŒïœïŒ ïŒâCH 2CH2CH3åã³ ãåŒãïŒ 7.07ã7.78ïŒïœïŒïŒããªãžã«ãããã³ïŒ 7.69ïŒïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.28ïŒd.dïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.64ïŒïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒã åæ§ã«å®æœããããšã«ãã€ãŠæ¬¡ã®ååç©ãåŸ
ãïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãšãã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ãèç¹291âã292âïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ãèç¹206âã207âïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ãèç¹229âã232âïŒ äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²ã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ã«ãâã¯ãã¢ã³ïŒ0.6ïœïŒãšãžã¡ãã«ãã«ã ã¢ãã
ïŒïŒmlïŒäžã®æ²åãšãã«ïŒ0.54ïœïŒåã³ç¡æ°Ž
K2CO3ïŒ0.63ïœïŒãšãæ¹æäžã«å®€æž©ã§ïŒæéåå¿
ããããæ°·æ°Žã§çšéåŸãæ²æ®¿ç©ãå¥ããã€ïœâ
ãããµã³ããæ¶åããããšããã©ã³ã¹âïŒâã«ã«
ããšããã·âïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ã
ããããã
ã«â2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³
ïŒèç¹95âã97âïŒ0.4ïœãåŸãããã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ1.3ïœïŒãšãžãªããµã³ïŒ30
mlïŒäžã®SOCl2ïŒ0.6mlïŒãšãéæµæž©åºŠã§ïŒæé
åå¿ãããã次ã«ã該åå¿æ··åç©ãç空äžã§èžçº
也涞ããã該æ®æ»ãããªãšãã«ã¢ãã³ïŒ0.5mlïŒ
ãå«æããç¡æ°Žãžãªããµã³ïŒ30mlïŒã«æº¶è§£ããã
ããïŒâãžãšãã«ã¢ããâãšã¿ããŒã«ïŒïŒmlïŒãš
宀枩ã§24æéåå¿ããããæ°Žã§çšéåŸãæ²æ®¿ç©ã
é ¢é žãšãã«ã§æœåºãã溶液ãç空äžã§èžçºä¹Ÿæ¶žã
ãã該æ®æ»ãã·ãªã«ã²ã«ã«ã©ã åã³æº¶é¢å€ãšããŠ
ã®ãã³ãŒã³âé ¢é žãšãã«ãçšããŠç²Ÿè£œããïŒãã©
ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒâãïŒ
âïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ãâã¯ãã¢ã³ãïŒâãžãšãã«ã¢ããâãšãã«ãš
ã¹ãã«ïŒæ²¹ç¶ç©ïŒ0.4ïœãåŸãããã N.M.R.ïŒCDCl3ïŒÎŽïŒ0.90ïŒïœïŒïŒâCH2CH2 CH
ïŒïŒ 1.10ïŒïœïŒãåŒã 1.55ïŒïœïŒïŒâCH2 CH 2CH3ïŒ 1.87ïŒïœïŒãåŒã 2.52ïŒïœïŒïŒâCH3ïŒ 2.71ïŒïœïŒãåŒã 2.50ã2.90ïŒïœïŒïŒâCH 2CH2CH3 åã³ãåŒã 2.95ïŒïœïŒïŒâOCH2 CH 2NãïŒ 4.49ïŒïœïŒïŒâCH 2CH2NãïŒ 6.96ã7.64ïŒïœïŒïŒããªãžã«ãããã³ïŒ 7.47(d)ïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.32ïŒïœã»ïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.93(d)ïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ1.6ïœïŒãååŠéè«çéã®
2N NaOHã«æº¶è§£ããã次ã«ã該溶液ãç空äžã§
æ¿çž®ããã€ã¢ã»ãã³ã§çšéãããæ²æ®¿ç©ãå¥ã
ãã€ã¢ã»ãã³ã§æŽæµããããã©ã³ã¹âïŒâã«ã«ã
ãã·âïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ãã«â
2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ãã
ããªãŠã å¡©ãèç¹ïŒ300âããåŸãã äŸ ïŒ æå¹ç©è³ª50mgãå«æããããããéé150mgã§
ããé å€ã次ã®ããã«è£œé ããïŒçµæ ïŒé å€10000åã«å¯ŸããŠïŒ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ 500ïœ ä¹³ ç³ 710ïœ ããŠã¢ãã³ã·æŸ±ç² 237.5ïœ ã¿ã«ã¯ç²æ« 37.5ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 15ïœ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ãä¹³ç³åã³ååéã®ããŠã¢ãã³
ã·æŸ±ç²ãæ··åããïŒæ¬¡ã«ã該混åç©ã0.5mmç®ã®
篩ã«éããããŠã¢ãã³ã·æŸ±ç²ïŒ18ïœïŒãç±æ°Ž
ïŒ180mlïŒã«æžæ¿ããããåŸãããããŒã¹ãã䜿çš
ããŠç²æ«ãé¡ç²ç¶ã«ããã該é¡ç²ã也ç¥ããã篩
ç®1.4mmã®ç¯©ã§çŽ°åãã次ã«æ®éã®æŸ±ç²ãã¿ã«ã¯
åã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãå ãã泚ææ·±ã
æ··åããçŽåŸïŒmmã®æé æ©ã䜿çšããŠé å€ã«å å·¥
ããã äŸ 10ãšã¢ãŸãŒã«åŠæ¹ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ ïŒïŒ ãšã¿ããŒã« 10ïŒ ã¬ã·ãã³ 0.2ïŒ ãžã¯ãã«ãžãã«ãªã«ã¡ã¿ã³ãšãžã¯ãã«ããã©ãã«
ãªã«ãšã¿ã³ãšã®æ··åç©ïŒ70ïŒ30æ··åç©ïŒ
100ïŒ ãŸã§ ããããã
ã³ããã®è£œé æ³ãªãã³ã«è©²ã¯ãã¢ã³ãå«æãã補
è¬åŠççµæç©ã«é¢ããã æ¬çºæã®ååç©ã¯æ¬¡ã®åŒïŒïŒã§ç€ºãããïŒ ïŒ»åŒäžãR1ã¯æ°ŽçŽ ååã§ãããåã¯ãåŒãåº ïŒããã§R4åã³R5ã¯ããããç¬ç«ã«C1âC4ã¢ã«ã
ã«åºã§ããïŒã«ãã€ãŠçœ®æããããåã¯çœ®æãã
ãŠããªãC1âC6âã¢ã«ãã«åºã§ãããR2ã¯C1â
C4ã¢ã«ãã«åºã§ãããR3ã¯ããªãžã«åºåã¯ã¡ã
ã«åºã«ãã€ãŠçœ®æãããããªãžã«åºãè¡šããã æ¬çºæã®ç®çç©ã¯ã補è¬åŠçã«èªå®¹æ§ã®åŒ
ïŒïŒã®ååç©ã®å¡©ã§ããããªãã³ã«å šãŠã®èã
ããããç°æ§äœåã³ãã®æ··åç©ã§ãããã æ¬çºæã®ååç©ã¯ãã·ã¹âã§ããã©ã³ã¹âç«äœ
é 眮ã§ããããαåã³Î²ççŽ ååäžã®ïŒåã®æ°ŽçŽ
ååãã·ã¯ããããã³ç°é¢ã«å¯ŸããŠåãåŽã®äžã«
ããå Žåã該ååç©ã¯ã·ã¹âç«äœé 眮ã§ãããã
ã®éããŸãåãã§ããããŸããã·ã¹âãšãã©ã³ã¹
âç°æ§äœãšã®æ··åç©ããæ¬çºæã®ç¯å²ã«å±ããã
æå©ã«ãæ¬çºæã®ååç©ã¯ããã©ã³ã¹âç«äœé 眮
ã§ããã R3åºäžã®çœ®æåºã®äœçœ®ã確èªããããã«ä»ã
ããçªå·ã¯ã次ã«ç€ºãããã«åžžçšã®ãã®ã§ããïŒ ã¢ã«ãã«åºãã¢ã«ã±ãã«åºãã¢ã«ã³ãã·åºåã³
ã¢ã«ã«ãã€ã«ãªãã·åºã¯ãåæéåã¯çŽéã®åºã§
ãã€ãŠããã R1ã¯çœ®æãããŠããªãC1âC6ã¢ã«ãã«åºãæ
å©ã§ãããç¹ã«ã¡ãã«åºããšãã«åºãã€ãœããã
ã«åºãïœâããã«åºåã³ããã·ã«åºã§ããã R4åã³ïŒåã¯R5ã¯æå©ã«C1ãC4ã¢ã«ãã«åºã
ç¹ã«ã¡ãã«åºããšãã«åºãã€ãœãããã«åºåã³ïœ
âããã«åºã§ããã ããããã
R2ã¯æå©ã«C2ãC3ã¢ã«ãã«åºãç¹ã«ãšãã«åº
åã³ãããã«åºã§ããããåã¯C3ã¢ã«ã±ãã«
åºãç¹ã«ã¢ãªã«åºã§ããã R3ãããªãžã«åºã§ããå ŽåãïŒâããªãžã«åº
ãæå©ã§ããã 補è¬åŠçã«èªå®¹æ§ã®å¡©ã®äŸã¯ãæ°Žé žåâãããª
ãŠã ãâã«ãªãŠã ãâã«ã«ã·ãŠã åã³âã¢ã«ãããŠ
ã ã®ãããªç¡æ©å¡©åºãšã®å¡©ã§ãã€ãŠããããããª
ãžã³ãããªãšãã«ã¢ãã³ãããªãšã¿ããŒã«ã¢ã
ã³ããžãã³ãžã«ã¢ãã³ãã¡ãã«ãã³ãžã«ã¢ãã³ã
ãžâïŒïŒâãšãã«âããã·ã«ïŒâã¢ãã³ããããªãž
ã³ãâãšãã«ãããªãžã³ãã»ïŒ®âãžãšãã«ã¢
ãããšãã«ã¢ãã³ãâãšãã«ã¢ã«ããªã³ãβâ
ããšããã«ã¢ãã³ãâãã³ãžã«âβâããšãã
ã«ã¢ãã³ãâãã³ãžã«âã»ïŒ®âãžã¡ãã«ã¢ã
ã³åã³ä»ã®èªå®¹æ§ææ©ã¢ãã³ã®ãããªææ©å¡©åºãš
ã®å¡©ããªãã³ã«ç¡æ©é žãäŸãã°å¡©åæ°ŽçŽ é žãèå
æ°ŽçŽ é žåã³ç¡«é žãªãã³ã«ææ©é žãäŸãã°ã¯ãšã³
é žãé ç³é žããã¬ã€ã³é žããªã³ãŽé žãããã«é žã
ã¡ã¿ã³ã¹ã«ãã³é žåã³ãšã¿ã³ã¹ã«ãã³é žãšã®å¡©ã§
ãã€ãŠãããã æå©ãªå¡©ã¯ããããªãŠã å¡©åã³ã«ãªãŠã å¡©ããª
ãã³ã«å¡©åºæ§ãšã¹ãã«ã®ãäŸãã°ãžãšãã«ã¢ãã
ãšãã«ãšã¹ãã«åã³ãžã¡ãã«ã¢ãããšãã«ãšã¹ã
ã«ã®ãããªãŠã å¡©ãã«ãªãŠã å¡©ã䞊ã³ã«å¡©é žå¡©ã§
ããã ç¹ã«ããããæ¬çºæã®ååç©ã¯ãåŒïŒïŒã®å
åç©ããã®å ŽåR1ã¯(a)æ°ŽçŽ ååã
ãåŒãåºãäœããR4åã³R5ã¯ãããã åäžããåã¯ç°ãªããC1ãC4ã¢ã«ãã«åºã§ã
ãïŒã«ãã€ãŠçœ®æãããããåã¯çœ®æãããŠããª
ãC1ãC6ã¢ã«ãã«åºã§ãããR2ã¯C1ãC4ã¢ã«ã
ã«åºãç¹ã«ãšãã«åºåã¯ãããã«åºã§ããããã
ããã¯C3âã¢ã«ã±ãã«åºãç¹ã«ã¢ãªã«åºã§ã
ããR3ã¯ïŒâããªãžã«åºã§ãããããããã¯ã¡
ãã«åºã«ãã€ãŠçœ®æãããïŒâããªãžã«åºã§ã
ããããªãã³ã«ãã®è£œè¬åŠçã«èªå®¹æ§ã®å¡©ã§ã
ãã æ¬çºæã®ããããååç©ã«ãããŠãâCOOR1åº
ã¯æå©ã«éé¢ã®åã¯å¡©ã«ãããã«ã«ããã·åºã§ã
ãã ç¹ã«ããããæ¬çºæã®ååç©ã®äŸã¯æ¬¡ã®ãã®ã§
ããïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãšãã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãããã®å¡©ãç¹ã«å¡©
åºæ§ãšã¹ãã«ïŒäŸãã°ïŒâãžãšãã«ã¢ãããšã¿ã
ãŒã«åã³ïŒâãžã¡ãã«ã¢ãããšã¿ããŒã«ãæãã
該ãšã¹ãã«ïŒãªãã³ã«ãã®C1ãC6ã¢ã«ãã«ãšã¹
ãã«ãç¹ã«ã¡ãã«ãšã¹ãã«ããšãã«ãšã¹ãã«ãã€
ãœãããã«ãšã¹ãã«ãïœâããã«ãšã¹ãã«åã³ã
ãã·ã«ãšã¹ãã«ã®ãããªãŠã å¡©åã¯å¡©é žå¡©ã æ¬çºæã®ååç©ã¯ã次ã®æ¹æ³ã«ãã€ãŠè£œé ãã
ãïŒ åŒïŒïŒïŒ ãåŒäžãR1ãR2åã³R3ã¯åèšã®ãã®ãè¡šãããã®
ååç©åã¯ãã®å¡©ãã·ã¯ããããã³åããå¿ èŠã«
å¿ããŠãåŒïŒïŒã®ååç©ãå ¬ç¥æ¹æ³ã«ãã€ãŠå
æ°Žå解åã¯ãšã¹ãã«åãããã€ïŒåã¯å¿ èŠã«å¿ã
ãŠãåŒïŒïŒã®ååç©ã補è¬åŠçã«èªå®¹æ§ã®å¡©ã«
å€æãããã€ïŒåã¯å¿ èŠã«å¿ããŠãå¡©ãéé¢åå
ç©ã«å€æããã€ïŒåã¯å¿ èŠã«å¿ããŠãç°æ§äœæ··å
ç©ãåé¢ããŠåç°æ§äœã«ããã åŒïŒïŒã®ååç©ã®ã·ã¯ããããã³åã¯ãæå©
ã«ãåŒïŒïŒã®ååç©ããžã¡ãã«ã¹ã«ãããœããŠ
ã ã¡ããªãïŒäŸãã°J.Chem.Soc.ã1967幎ã第
2495é ã«èšèŒãããŠããæ¹æ³ã«ãã€ãŠè£œé ïŒãšå
å¿ãããäŸãã°ãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«
ããããã
ã¹ã«ããã·ãããžãªããµã³åã³ãããã®æ··åç©ã
ãæã矀ããéžæãããäžæŽ»æ§ææ©æº¶å€äžã§ãæ
å©ã«çŽïŒâãçŽ50âã®ç¯å²å ã®æž©åºŠã§åŠçããã
ãšã«ãã€ãŠå®æœããããšãã§ããã åŒïŒïŒã®ååç©ã¯äžèšã®ããã«ãå ¬ç¥æ¹æ³ã«
ãã€ãŠãåŒïŒïŒã®ä»ã®ååç©ã«å€æããããšã
ã§ãïŒäŸãã°ãåŒïŒïŒã®ååç©ïŒããã§ãâ
COOR1åºã¯ãšã¹ãã«åãããã«ã«ããã·åºã§ã
ãïŒã¯ãå æ°Žå解äŸãã°æ°Žåã¯äœçŽèèªæã¢ã«ã³
ãŒã«ã®ãããªæº¶å€äžã®äŸãã°æ°Žé žåãããªãŠã å
ã¯æ°Žé žåã«ãªãŠã ã䜿çšãã宀枩çŽ150âã®ç¯å²
å ã®æž©åºŠã§åŠçããå¡©åºæ§å æ°Žå解ãã«ãã€ãŠåŒ
ïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åºã¯ã«ã«ã
ãã·åºã§ããïŒã«å€æããããšãã§ããåãåå¿
ã¯ãäŸãã°50âããé«ã枩床ã§ããžã¡ãã«ãã«ã
ã¢ããäžã®èåãªããŠã ãçšããåŠçã«ãã€ãŠå®
æœããããšãã§ããã ç¹ã«ãåŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1
åºã¯ïœâãããã·ã«ã«ããã«åºã§ããïŒã¯ãäŸã
ã°æº¶å€ã®äžåšäžã«ããããã¯äŸãã°ãã³ãŒã³ãã
ã«ãšã³ããžãªããµã³ãããªã矀ããéžæãããäž
掻æ§ææ©æº¶å€ã®ååšäžã«ãçŽïŒâãçŽ50âã®ç¯å²
å ã®æž©åºŠã§ãããªãã«ãªã«é ¢é žãçšããåŠçã«ã
ã€ãŠãåŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åº
ã¯ã«ã«ããã·åºã§ããïŒã«å€æããããšãã§ãã
ãããã¯äŸãã°ïŒãžã€ãŒãã«ã»ãªãã»ãŒã»ã¢ã¡ãª
ã«ã³ã»ã±ãã«ã«ã»ãœãµã€ãšãã€âïŒJ.Am.Chem.
Soc.ïŒâ第99å·»ã第968é ã1977幎ã«èšèŒãããŠã
ãæ¹æ³ã«ãã€ãŠäžæŽ»æ§ææ©æº¶å€ãæå©ã«ããã©ã¯
ãã«ã¡ã¿ã³äžã®ããªã¡ãã«ãšãŒãã€ããçšããåŠ
çã«ãã€ãŠå€æããããšãã§ããã åŒïŒïŒã®ååç©ïŒãã®å ŽåãâCOOR1åºã¯ã«
ã«ããã·åºã§ããïŒã¯ãåžžæ³ã«ãã€ãŠãäŸãã°é ž
ã®ã¢ã«ã«ãªå¡©ãé©åœãªã¢ã«ãã«ããã²ã³åç©ãšã
äŸãã°ã¢ã»ãã³ããžãªããµã³ããžã¡ãã«ãã«ã ã¢
ããããããµã¡ãã«ãã¹ãã¹ããªã¢ããã®ãããª
äžæŽ»æ§æº¶å€äžã§çŽïŒâãçŽ100âã®ç¯å²å ã®æž©åºŠ
ã§åå¿ãããããšã«ãã€ãŠåŒïŒïŒã®ååç©ãã
ã®å ŽåãâCOOR1åºã¯ãšã¹ãã«åãããã«ã«ãã
ã·åºãäŸãã°ãåŒãåºïŒäœããR4åã³R5㯠åèšã®ãã®ãè¡šããïŒã«ãã€ãŠçœ®æãããããå
ã¯çœ®æãããŠããªãã«ã«ãã¢ã«ã³ãã·åºã§ããã
ã«å€æããããšãã§ããã ãŸããåŒïŒïŒã®ååç©ã®ãšã¹ãã«åã¯ã(a)äŸ
ãã°æº¶å€ã®äžåšäžãããã¯äŸãã°ãã³ãŒã³ããã«
ãšã³ããã·ã¬ã³ããžãªããµã³ããžã¯ãã«ãšã¿ã³ã
å¡©åã¡ãã¬ã³ãããã©ããããã©ã³ã®ãããªäžæŽ»
æ§ææ©æº¶å€äžã§æå©ã«çŽïŒâãçŽ120âã®ç¯å²å
ã®æž©åºŠã§ãææã®é žããã²ã³åç©ãäŸãã°å¡©åãª
ããµãªã«ãå¡©åããªãã«ãPCl3ãPCl5åã¯POCl3
ãšåå¿ãããããšã«ãã€ãŠãåŒïŒïŒã®ååç©
ïŒãã®å ŽåãâCOOR1åºã¯ã«ã«ããã·åºã§ããïŒ
ãçžå¿ããããã«ã«ããã«ãæå©ã«ã¯ãã«ã«ã«ã
ãã«ãèªå°äœã«å€ãïŒæ¬¡ã«(b)åŸãããããã«ã«ã
ãã«èªå°äœãé©åœãªåŒR1âOHã®ã¢ã«ã³ãŒã«ïŒã
ã®å ŽåãR1ã¯åèšã®ãã®ãè¡šããïŒãšãäŸãã°
ãã³ãŒã³ããã«ãšã³ããã·ã¬ã³ããžãªããµã³ããž
ã¯ãã«ãšã¿ã³ãå¡©åã¡ãã¬ã³ãããã©ããããã©
ã³ã®ãããªäžæŽ»æ§æº¶å€äžã§ãçŽïŒâãçŽ120âã®
ç¯å²å ã®æž©åºŠã§ãæå©ã«äŸãã°ããªãšãã«ã¢ãã³
åã¯ãžãšãã«ã¢ãã³ã®ãããªå¡©åºã®ååšäžã«åå¿
ãããŠå®æœããããšãã§ããã ãŸããåŒïŒïŒã®ååç©ã®å Žåã«ããé å¡©ãªã
ã³ã«å¡©ã®éé¢ååç©ãžã®å€æåã³ç°æ§äœæ··åç©ã®
åç°æ§äœãžã®åé¢ã¯ãåžžæ³ã«ãã€ãŠå®æœããããš
ãã§ããã äŸãã°ãå Žåã«ãã察æäœã®å察æäœãžã®åé¢
ã¯ãå Žåã«ãã掻æ§å¡©åºãçšããé å¡©åã³åŒç¶ã
åå¥çµæ¶ã«ãã€ãŠå®æœããããšãã§ãããããªã
ã¡ãã·ã¹âåã³ãã©ã³ã¹â幟äœåŠçç°æ§äœæ··åç©
ã®åé¢ã¯ãäŸãã°åå¥çµæ¶ã«ãã€ãŠå®æœããããš
ãã§ããã åŒïŒïŒã®ååç©ã¯ãäŸãã°ãã«ã®ãŒç¹èš±æ现
æžç¬¬855657å·ã«çžå¿ãã西ãã€ãåœç¹èš±åºé¡å ¬é
第P2725932å·æ现æžã«èšèŒãããæ¹æ³ã«ãã€ãŠ
補é ããããšãã§ããã æ¬çºæã®ååç©ã¯æã¢ã¬ã«ã®ãŒäœçšãæããã
ãšãèªãããããããã€ãŠã¢ã¬ã«ã®ãŒæºã®å šãŠã®
çŸç ãäŸãã°æ°ç®¡æ¯åæ¯ãã¢ã¬ã«ã®ãŒæ§éŒ»çãæ¯
èç±ãè麻ç¹åã³ç®èç ã®äºé²åã³æ²»çã«æå¹ã§
ããã æ¬çºæã®ååç©ã®æã¢ã¬ã«ã®ãŒäœçšã¯ãäŸãã°
該ååç©ãã°ãŒã¹ïŒGooseïŒJ.åã³ãã¬ã¢
ïŒBlairïŒA.M.J.NïŒImmunologyã第16å·»ã第749
é ã1969幎ïŒã«ããããºãã®ååç®èéææ§çŸè±¡
ïŒPCAïŒè©Šéšã«ãããŠæå¹ã§ããäºå®ã«ãã€ãŠæ
ããããã
ããã§ããã æ¬çºæã®ååç©ã®éèŠãªç¹æ§ã¯ã該ååç©ãçµ
å£æäžã®å Žåã«ã¯æã¢ã¬ã«ã®ãŒäœçšã®é«ãå¹³åã
瀺ãããšã§ããã 次衚ã¯ãããºãã®PCAè©Šéšã«ãããå ¬ç¥ã®æ
ã¢ã¬ã«ã®ãŒæ§å»è¬ãžãããªãŠã ã¯ãã¢ã°ãªã±ãŒã
ïŒDSCGïŒãšæ¯èŒããŠãã©ã³ã¹ïŒâã«ã«ããã·â
ïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããª
ãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ïŒK13804ïŒã
ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ïŒœâã¯ãã¢
ã³ïŒFCE20251ïŒããã©ã³ã¹ïŒâã«ã«ããã·âïŒ
âãšãã«âïŒâïŒâïŒ6â²âã¡ãã«â2â²âããªãž
ã«ïŒâã·ã¯ããããã«ïŒœâã¯ãã¢ã³
ïŒFCE20250ïŒããã©ã³ã¹ïŒâã«ã«ããã·âïŒâã
ããã«âïŒâïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒ
âã·ã¯ããããã«ïŒœã¯ãã¢ã³ïŒFCE20417ïŒãã
ã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâïŒ
âïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ïŒœâã¯ãã¢ã³ïŒFCE20501ïŒãçµå£æäžããåŸ
ã«åŸãããäœçšå€ã瀺ãã äœçšããŒã¿ã¯ãæäœã«äœ¿çšãããè¡æž ã®æŽ»éã
ååãŸã§æžå°ãããããšã®ã§ãã掻æ§ååç©ã®é©
çšéãšããŠå®çŸ©ãããèšå·ïŒ«Bã§è¡šããããïŒ ïŒ«BïŒïŒ¢ïŒïŒ€ïŒ²âïŒ åŒäžã ïŒmgïŒKgã§è¡šããããæ®æäœçšååç©ã®é©çš
éïŒ DRïŒé©çšéæ¯çïŒæ®æç©è³ªãçšããè¡æž ã®é©çš
éå¹æ察æ°é¢æ°ãšæ®æç©è³ªãçšããªã該é¢ä¿ãš
ã®å·®ã®é察æ°ïŒJ.H.Gaddumä»ãExp.Physiol.
ã1955幎ã第40å·»ã第49é åç §ïŒã ããã§ãBãéžæãããããããšããã®ãã
ã®å€ã¯ç¬ç«ããŠè¬å€é©çšéåã³æäœã«äœ¿çšããã
ã¬ã¢ã®ã³æ¿åºŠã®åæ¹ã«ç¡é¢ä¿ã§ããããã§ããã Bå€ãäœããã°äœãã»ã©ãæã¢ã¬ã«ã®ãŒäœçš
ã¯äžå±€é«ããªãã ãè¡šã ãè¡šã æã¢ã¬ã«ã®ãŒäœçšã¯ãã¢ã¿ïŒMotaïŒïŒ©ãâã€ã
ãŠããžãŒïŒImmunologyïŒâã第ïŒå·»ã第681é ã
1964幎ã®æ¹æ³ã«åŸããããºãã«ãããŠå¢å€§ããã
å皮现è芪åæ§æäœã䜿çšããŠã°ãŒã¹ïŒGooseïŒ
J.åã³ãã¬ã¢ïŒBlairïŒA.M.J.NïŒäžèšåŒçšæäžïŒ
ã«ããlgEâéæ¥PCAã®æå¶ã«ãã€ãŠæž¬å®ããã è©Šéšååç©ããæåé©çš15ååã«çµå£ïŒp.o.ïŒ
æäžãïŒå°ãªããšãïŒå¹ã®ããºããåæäžéã«å¯Ÿ
ããŠäœ¿çšããã çµå£æäžåŸïŒæ¥éã«ç€ºãããæ¥æ§æ¯æ§ã¯ãæ¬çº
æã®ååç©ã®æçšæ§ãè©äŸ¡ãããã®ã§ãã€ããäŸ
ãã°ããã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«
âïŒâãïŒâïŒ6â²âã¡ãã«2â²âããªãžã«ïŒâã·ã¯ã
ãããã«ãâã¯ãã¢ã³ã¯ãããºãã«ãããŠLD50ïŒ
400mgïŒKgã瀺ããã æŽã«ãæ¬çºæã®ååç©ã¯ãã¿ã«ã®ïŒTakagiïŒ
K.åã³ãªã«ãïŒOkabeïŒS.ã«ãã€ãŠèšèŒãããæ¹
æ³ïŒJap.J.of Pharmac.ã1968幎ã第19å·»ïŒç¬¬ïŒ
å·ïŒã®å€åœ¢ã«ãã25âã§40åé氎济äžã«ææãã
ããºãã®ã¹ãã¬ã¹èªçºæœ°çã®æå¶ã«äœçšããããš
ãå€æããäºå®ã«ãã€ãŠèšŒæããããããªæ朰ç
äœçšãæããã ãŸããæ¬çºæã®ååç©ã¯ããããã«ã³ããšãã
ïŒKanzettïŒåã³ã¬ã¹ã©ãŒïŒRosslerïŒãArch.Exp.
Path.Pharmakol.ã第71å·»ã第195é ã1940幎ã®
æ¹æ³ã«ããã¢ã«ã¢ããã®ãã¹ã¿ãã³ã«ãã€ãŠèªçº
ãããæ°ç®¡æ¯çæã®æå¶ã«äœçšããããšãå€æã
ãäºå®ã«ãã€ãŠç€ºãããããã«æ°ç®¡æ¯æ¡åŒµäœçšã
èªããããã æ¬çºæã®ååç©ã¯ãåžžæ³ã§ãäŸãã°çµå£çåã³
éçµå£çã«æå©ã«0.5ã15mgïŒKgã®ïŒæ¥éã§æçš
ããããšãã§ããããåã¯åžå ¥ã«ãã€ãŠæå©ã«äž
æ¥é0.5ã100mgãæå©ã«0.5ã25mgã®ïŒæ¥éã§æ
äžããããšãã§ããããåã¯å±æå¿çšã«ãã€ãŠã
äŸãã°ä¹³å€100mgãããæå¹æåçŽ0.5ãïŒmgãæ
å©ã«ïŒãïŒmgãæããä¹³å€ã§é©çšããããšãã§ã
ããããã
ãã å¿è«ã補è¬åŠçã«èªå®¹æ§ã®ãã€ãªã€ãŒåã¯åžé
å€ãšçµåããæ¬çºæã®ååç©ãæãã補è¬åŠççµ
æç©ã®æ§è³ªã¯ãææãããé©çšæ¹æ³ã«äŸåããã 該çµæç©ã¯ãåžžæ³ã§ãæ®éã®æåãçšããŠè£œé
ããããšãã§ãããäŸãã°ãæ¬çºæã®ååç©ã¯ã
æ°Žæ§åã¯æ²¹æ§æº¶æ¶²åã¯æžæ¿æ¶²ããšãŒããŸã«ããªã
ã³ã«ç²æ«ãé å€ãäžžå€ããŒã©ãã³ã«ãã»ã«ãã·ã
ãããç¹æ»Žå€ãåè¬åã¯ã¯ãªãŒã ããããã¯å±æ
çšããŒã·ãšã³ã®åœ¢ã§é©çšããããšãã§ããã åŸã€ãŠãçµå£æäžããããã®æ¬çºæã®ååç©ã
æãã補è¬åŠççµæç©ã¯ãæå©ã«ãäœçšç©è³ªãåž
éå€äŸãã°ä¹³ç³ãããã¹ãããŒã¹ãçœç³ããã³ã
ããŒã«ããœã«ãããŒã«ãã»ã«ããŒã¹ïŒæœ€æ»å€ãäŸ
ãã°ã·ãªã«ãã¿ã«ã¯ãã¹ãã¢ãªã³é žãã¹ãã¢ãªã³
é žãã°ãã·ãŠã åã¯ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãå
ã³ïŒåã¯ããªãšãã¬ã³ã°ãªã³ãŒã«ãšäžç·ã«å«æã
ãé å€ãäžžå€åã¯ãŒã©ãã³ã«ãã»ã«ã§ãããå
ã¯ã該çµæç©ã¯çµåå€äŸãã°æŸ±ç²ããŒã©ãã³ãã¡
ãã«ã»ã«ããŒã¹ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã
ã¢ã©ãã¢ãŽã ããã©ã¬ã«ã³ããããªããã«ãããª
ãã³ã厩å£å€äŸãã°æŸ±ç²ãã¢ã«ã®ã³é žãã¢ã«ã®ã³
é žå¡©ãã°ã«ã³ãŒã«é žãããªãŠã 柱ç²ïŒæ²žéš°æ§æ··å
ç©ïŒè²çŽ ïŒçå³æã湿最å€äŸãã°ã¬ã·ãã³ãããª
ãœã«ããŒããã©ãŠãªã«ã¹ã«ããšãŒãåã³äžè¬ã«è£œ
è¬åŠçé åã«äœ¿çšãããç¡å®³ã§ãã€è¬ç©åŠçåŠæ¹
ã«äœ¿çšãããäžæŽ»æ§ã®ç©è³ªãšå ±ã«ãå«æããŠããŠ
ããã該補å€ã¯ãå ¬ç¥æ¹æ³ã§ãäŸãã°æ··åãç²
ç ãã¿ãã¬ãããç ç³ã³ãŒãã€ã³ã°ãåã¯èã³ãŒ
ãã€ã³ã°ã«ãã€ãŠè£œé ããããšãã§ããã ã¢ã¬ã«ã®ãŒæ§åæ¯ã®æ²»çã®ããã«ãæ¬çºæã®å
åç©ã¯åžå ¥ã«ããé©çšãããããã®ãããªçšæ³ã®
ããã«ãé©åœãªçµæç©ããæå©ã«åžžçšã®åŽé§åšã«
ãã€ãŠæäžãããæ°Žäžã®ãããªãŠã å¡©ã®ãããªå¡©
ã®åœ¢ã®æå¹æåã®æžæ¿æ¶²åã¯æº¶æ¶²ãããªã€ãŠããŠ
ããããŸãã該çµæç©ã¯ãå å§å®¹åšãäŸãã°ãšã¢
ãŸãŒã«ãã€ã¹ãã³ãµãŒããæäžããããžã¯ãã«ãž
ãã«ãªã«ã¡ã¿ã³åã¯ãžã¯ãã«ããã©ãã«ãªã«ãšã¿
ã³ã®ãããªæ®éã®æ¶²äœåŽå°è¬äžã®æå¹æåã®æžæ¿
液åã¯æº¶æ¶²ãããªã€ãŠããŠããããè¬ç©ãåŽå°è¬
ã«æº¶è§£äžèœã§ããå Žåã«ã¯ããšã¿ããŒã«ããžãã
ãã¬ã³ã°ãªã³ãŒã«ãã€ãœãããã«ããªã¹ããŒãã®
ãããªè£å©æº¶å€ãªãã³ã«ïŒãããã¯è¬ç©ãåŽå°è¬
åªäœã«æžæ¿ãããããã«çé¢æŽ»æ§å€ã®çµæç©ãžã®
æ·»å ãå¿ èŠã§ãã€ãŠãããããã®ãããªçé¢æŽ»æ§
å€ã¯ã該ç®çã®ããã«æ®éã«äœ¿çšããããäŸãã°
éã€ãªã³çé掻æ§å€ãäŸãã°ã¬ã·ãã³ã§ãã€ãŠã
ãããæ¬çºæã®ååç©ã¯ãé©åœãªç©ºæ°åžå ¥åšã«ã
ã€ãŠç²æ«ã®åœ¢ã§æäžããããšãã§ãããã®å Žåæ
å¹æåã®åŸ®çŽ°ç²åç¶ç²æ«ã¯ãä¹³ç³ã®ãããªåžéç©
質ãšæ··åããããšãã§ããã æŽã«ãæ¬çºæã®ååç©ã¯ãåžžæ³ã§ç®å åã¯éè
å 泚å°ã«ãã€ãŠæäžããããšãã§ããã ãã®å çšã«å ããŠãæ¬çºæã®ååç©ã¯ãå±æé©
çšã®çµæç©ãäŸãã°ç®èç§åŠçæ²»çã«äœ¿çšããã
ã¯ãªãŒã ãããŒã·ãšã³åã¯ããŒã¹ããšããŠäœ¿çšã
ãããšãã§ããããã®çµæç©ã«å¯ŸããŠãæå¹æå
ã¯åžžçšã®æ²¹æ§åã¯ä¹³å賊圢å€ãšæ··åããããšãã§
ããã æ¬çºæã次ã®å®æœäŸã«ãã€ãŠè©³èª¬ãããããã®
å®æœäŸã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãã äŸ ïŒ ããªã¡ãã«âã¹ã«ãããœããŠã ãšãŒãã€ã
ïŒ2.86ïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ30mlïŒäžã®
50ïŒ æ°ŽçŽ åãããªãŠã ïŒ0.62ïœïŒãšæ¹æäžã«å®€æž©
ã§ïŒæéåå¿ããã次ã«ãžã¡ãã«ãã«ã ã¢ãã
ïŒ30mlïŒäžã®ãã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒ
âãããã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâãã
ã«ãâã¯ãã¢ã³ïŒ3.59ïœïŒã®æº¶æ¶²ãå ããã該混
åç©ãæ¹æäžã«å®€æž©ã§90åéåå¿ããã次ã«æ°·æ°Ž
ã§åžéããé ¢é žãšãã«ã§æœåºãïŒææ©çžãïŒïŒ
NaHCO3åã³æ°Žã§äžæ§ã«ãªããŸã§æŽæµãããç空
äžã§èžçºä¹Ÿåºãããã¡ã¿ããŒã«ããæ¶åºããã
ãšããã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒâããã
ã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ãâã¯ãã¢ã³ïŒ2.3ïœèç¹180âã182âïŒãåŸã
ãããããããã95ïŒ ãšã¿ããŒã«æº¶æ¶²ïŒ40mlïŒäž
ã®ïŒïŒ KOHãšéæµæž©åºŠã§30åéåå¿ããããå·
åŽåŸã«ã該åå¿æ··åç©ã10ïŒ NaH2PO4ã§é žæ§ã«
ããç空äžã§æ¿çž®ããæ°Žã§åžéãïŒæ²æ®¿ç©ãå¥
ããæ°Žã§æŽæµãããã€ãœãããããŒã«ããæ¶åºã
ãããšãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«
âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâ
ã¯ãã¢ã³ïŒ1.5ïœïŒãåŸãããã äŸ ïŒ äŸïŒã«åŸã€ãŠå®æœãã次ã®ååç©ã補é ããïŒ
ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâã¡ãã«âïŒâ
ãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢
ããããã
ã³ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâããã«âïŒâ
ãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢
ã³ã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒïŒïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ70mlïŒäž
ã®æ²åã¡ãã«ïŒ5.2ïœïŒåã³ç¡æ°ŽK2CO3ïŒ6.3ïœïŒ
ãšã宀枩ã§ïŒæéæ¹æäžã«åå¿ããããæ°·æ°Žã§çš
éã®åŸã«ãæ²æ®¿ãéããã€ãœãããã«ãšãŒãã«
ããæ¶åºãããããã©ã³ã¹âïŒâã«ã«ããã·âïŒ
âãããã«âïŒâãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ã
ãããã«ãâã¯ãã¢ã³ã¡ãã«ãšã¹ãã«ïŒ6.1ïœïŒ
ïŒèç¹180ã182âïŒãåŸãããã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ã
ã¢ã³ïŒ3.0ïœïŒããžã¡ãã«ãã«ã ã¢ããïŒ40mlïŒ
äžã®ïŒâã¯ãã«âïŒâãžãšãã«ã¢ããâãšã¿ã³
ïŒ2.7ïœïŒåã³ç¡æ°ŽK2CO3ïŒ2.8ïœïŒãšãæ¹æäžã«
20âã§ïŒæéåå¿ããããæ°Žã§çšéã®åŸã«ãæ²æ®¿
ãéããäžæ§ã«ãªããŸã§æ°Žã§æŽæµããã€ãœãã
ãã«ãšãŒãã«ããæ¶åºããããšããã©ã³ã¹âïŒâ
ã«ã«ããã·âïŒâãããã«âïŒâãïŒâïŒ2â²âããª
ãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ïŒâãžãšãã«
ã¢ãããšãã«ãšã¹ãã«ïŒ1.8ïœïŒãåŸãããã äŸ ïŒ ããªã¡ãã«ã¹ã«ãããœããŠã ãšãŒãžãïŒ3.46
ïœïŒãšãžã¡ãã«ãã«ã ã¢ããïŒ50mlïŒäžã®50ïŒ æ°Ž
çŽ åãããªãŠã ïŒ0.76ïœïŒãšããæ¹æäžã«å®€æž©ã§
ïŒæéåå¿ããã次ã«ãžã¡ãã«ãã«ã ã¢ããïŒ50
mlïŒäžã®ãã©ã³ã¹âïŒâã«ã«ãã¡ããã·âïŒâã
ããã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒ
âãšããã«ãâã¯ãã¢ã³ãèç¹161âã164âã
ïŒ3.8ïœïŒã®æº¶æ¶²ãæ·»å ããã該混åç©ãæ¹æäžã«
宀枩ã§ïŒæéåå¿ããã次ã«ãããæ°·æ°Žã§çšéã
ããæ²æ®¿ç©ãé ¢é žãšãã«ã§æœåºãã溶液ãç空äž
ã§èžçºä¹Ÿæ¶žãããããããŠåŸããããã©ã³ã¹âïŒ
âã«ã«ãã¡ããã·âïŒâãããã«âïŒâãïŒâ
ïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããããã«ã
âã¯ãã¢ã³ïŒ3.9ïœïŒã95ïŒ ãšã¿ããŒã«æº¶æ¶²
ïŒ67.6mlïŒäžã®ïŒïŒ KOHãšéæµæž©åºŠã§10åéåå¿
ããããå·åŽåŸã該åå¿æ··åç©ãæ°·æ°Žã§çšéãã
ã€NaHPO4ã§äžåããæ²æ®¿ç©ãéããã€äžåã
ãããŸã§æ°Žã§æŽæµãããïŒâãã¿ãã³ããæ¶åºã
ãããšããã©ã³ã¹âïŒâã«ã«ããã·âïŒâããã
ã«âïŒâãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·
ã¯ããããã«ãâã¯ãã¢ã³1.4ïœãåŸããããèç¹
216âã217âïŒ I.R.ïŒKBrïŒïŒÎœïŒïŒ£ïŒïŒ¯ïŒé ž1710cm-1 ÎœïŒïŒ£ïŒïŒ¯ïŒã¯ãã¢ã³1640ã1620cm-1 N.M.R.ïŒDMSOâd6ïŒÎŽïŒ0.82ïŒïœïŒïŒâCH2CH2
CH ïŒïŒ 1.44ïŒïœïŒïŒâCH2 CH 2CH3ïŒ 1.85ïŒïœïŒãåŒã 2.47ïŒïœïŒïŒâCH3ïŒ 2.40ã3.04ïŒïœïŒ ïŒâCH 2CH2CH3åã³ ãåŒãïŒ 7.07ã7.78ïŒïœïŒïŒããªãžã«ãããã³ïŒ 7.69ïŒïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.28ïŒd.dïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.64ïŒïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒã åæ§ã«å®æœããããšã«ãã€ãŠæ¬¡ã®ååç©ãåŸ
ãïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãšãã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ãèç¹291âã292âïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ãèç¹206âã207âïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ãèç¹229âã232âïŒ äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²ã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ã«ãâã¯ãã¢ã³ïŒ0.6ïœïŒãšãžã¡ãã«ãã«ã ã¢ãã
ïŒïŒmlïŒäžã®æ²åãšãã«ïŒ0.54ïœïŒåã³ç¡æ°Ž
K2CO3ïŒ0.63ïœïŒãšãæ¹æäžã«å®€æž©ã§ïŒæéåå¿
ããããæ°·æ°Žã§çšéåŸãæ²æ®¿ç©ãå¥ããã€ïœâ
ãããµã³ããæ¶åããããšããã©ã³ã¹âïŒâã«ã«
ããšããã·âïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ã
ããããã
ã«â2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³
ïŒèç¹95âã97âïŒ0.4ïœãåŸãããã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ1.3ïœïŒãšãžãªããµã³ïŒ30
mlïŒäžã®SOCl2ïŒ0.6mlïŒãšãéæµæž©åºŠã§ïŒæé
åå¿ãããã次ã«ã該åå¿æ··åç©ãç空äžã§èžçº
也涞ããã該æ®æ»ãããªãšãã«ã¢ãã³ïŒ0.5mlïŒ
ãå«æããç¡æ°Žãžãªããµã³ïŒ30mlïŒã«æº¶è§£ããã
ããïŒâãžãšãã«ã¢ããâãšã¿ããŒã«ïŒïŒmlïŒãš
宀枩ã§24æéåå¿ããããæ°Žã§çšéåŸãæ²æ®¿ç©ã
é ¢é žãšãã«ã§æœåºãã溶液ãç空äžã§èžçºä¹Ÿæ¶žã
ãã該æ®æ»ãã·ãªã«ã²ã«ã«ã©ã åã³æº¶é¢å€ãšããŠ
ã®ãã³ãŒã³âé ¢é žãšãã«ãçšããŠç²Ÿè£œããïŒãã©
ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒâãïŒ
âïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãããã
ã«ãâã¯ãã¢ã³ãïŒâãžãšãã«ã¢ããâãšãã«ãš
ã¹ãã«ïŒæ²¹ç¶ç©ïŒ0.4ïœãåŸãããã N.M.R.ïŒCDCl3ïŒÎŽïŒ0.90ïŒïœïŒïŒâCH2CH2 CH
ïŒïŒ 1.10ïŒïœïŒãåŒã 1.55ïŒïœïŒïŒâCH2 CH 2CH3ïŒ 1.87ïŒïœïŒãåŒã 2.52ïŒïœïŒïŒâCH3ïŒ 2.71ïŒïœïŒãåŒã 2.50ã2.90ïŒïœïŒïŒâCH 2CH2CH3 åã³ãåŒã 2.95ïŒïœïŒïŒâOCH2 CH 2NãïŒ 4.49ïŒïœïŒïŒâCH 2CH2NãïŒ 6.96ã7.64ïŒïœïŒïŒããªãžã«ãããã³ïŒ 7.47(d)ïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.32ïŒïœã»ïœïŒïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒ 8.93(d)ïŒïŒ£âïŒã¯ãã¢ãã«ãããã³ïŒã äŸ ïŒ ãã©ã³ã¹âïŒâã«ã«ããã·âïŒâãããã«âïŒ
âãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ãã
ããã«ãâã¯ãã¢ã³ïŒ1.6ïœïŒãååŠéè«çéã®
2N NaOHã«æº¶è§£ããã次ã«ã該溶液ãç空äžã§
æ¿çž®ããã€ã¢ã»ãã³ã§çšéãããæ²æ®¿ç©ãå¥ã
ãã€ã¢ã»ãã³ã§æŽæµããããã©ã³ã¹âïŒâã«ã«ã
ãã·âïŒâãããã«âïŒâãïŒâïŒ6â²âã¡ãã«â
2â²âããªãžã«ïŒâã·ã¯ããããã«ãâã¯ãã¢ã³ãã
ããªãŠã å¡©ãèç¹ïŒ300âããåŸãã äŸ ïŒ æå¹ç©è³ª50mgãå«æããããããéé150mgã§
ããé å€ã次ã®ããã«è£œé ããïŒçµæ ïŒé å€10000åã«å¯ŸããŠïŒ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ 500ïœ ä¹³ ç³ 710ïœ ããŠã¢ãã³ã·æŸ±ç² 237.5ïœ ã¿ã«ã¯ç²æ« 37.5ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 15ïœ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ãä¹³ç³åã³ååéã®ããŠã¢ãã³
ã·æŸ±ç²ãæ··åããïŒæ¬¡ã«ã該混åç©ã0.5mmç®ã®
篩ã«éããããŠã¢ãã³ã·æŸ±ç²ïŒ18ïœïŒãç±æ°Ž
ïŒ180mlïŒã«æžæ¿ããããåŸãããããŒã¹ãã䜿çš
ããŠç²æ«ãé¡ç²ç¶ã«ããã該é¡ç²ã也ç¥ããã篩
ç®1.4mmã®ç¯©ã§çŽ°åãã次ã«æ®éã®æŸ±ç²ãã¿ã«ã¯
åã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãå ãã泚ææ·±ã
æ··åããçŽåŸïŒmmã®æé æ©ã䜿çšããŠé å€ã«å å·¥
ããã äŸ 10ãšã¢ãŸãŒã«åŠæ¹ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ãïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ãâã¯ãã¢ã³ ïŒïŒ ãšã¿ããŒã« 10ïŒ ã¬ã·ãã³ 0.2ïŒ ãžã¯ãã«ãžãã«ãªã«ã¡ã¿ã³ãšãžã¯ãã«ããã©ãã«
ãªã«ãšã¿ã³ãšã®æ··åç©ïŒ70ïŒ30æ··åç©ïŒ
100ïŒ ãŸã§ ããããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒïŒïŒïŒ åŒäžãR1ã¯æ°ŽçŽ ååã§ãããåã¯ãåŒãåº ïŒããã§ãR4åã³R5ã¯ãããããç¬ç«ã«C1âC4ã¢
ã«ãã«åºããéžæãããåºã§ããïŒã«ãã€ãŠçœ®æ
ããããåã¯çœ®æãããŠããªãC1âC6ã¢ã«ãã«
åºã§ãããR2ã¯C1âC4ã¢ã«ãã«åºã§ãããR3ã¯
ããªãžã«åºåã¯ã¡ãã«åºã«ãã€ãŠçœ®æãããããª
ãžã«åºãè¡šããã®ååç©ãªãã³ã«è£œè¬åŠçã«èª
容æ§ã®ãã®å¡©ã ïŒ æ¬¡ã®çŸ€ïŒ ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ïŒâïŒ2â²âããªãžã«ïŒâã·ã¯ããããã«ïŒœâã¯ãã¢
ã³ã ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ããããã
ïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ïŒœâã¯ãã¢ã³ã ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãšãã«âïŒâ
ïŒâïŒ6â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ïŒœâã¯ãã¢ã³ã ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ïŒâïŒ5â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ïŒœâã¯ãã¢ã³ã ãã©ã³ã¹ïŒâã«ã«ããã·âïŒâãããã«âïŒâ
ïŒâïŒ4â²âã¡ãã«â2â²âããªãžã«ïŒâã·ã¯ããã
ãã«ïŒœâã¯ãã¢ã³ã ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãããã®å¡©åã³C1
âC6ã¢ã«ãã«ãšã¹ãã«ããéžæããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ å¡©ããããªãŠã å¡©ã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã®å¡©ã ïŒ å¡©ã¯ãã®å¡©åºæ§ãšã¹ãã«ã®å¡©é žå¡©ã§ãããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã®å¡©ã ïŒ å¡©åºæ§ãšã¹ãã«ã¯ïŒâãžãšãã«ã¢ãããšã¿ã
ãŒã«åã¯ïŒâãžã¡ãã«ã¢ãããšã¿ããŒã«ãšã¹ãã«
ã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ C1âC6ã¢ã«ãã«åºã¯ã¡ãã«åºããšãã«åºã
ã€ãœãããã«åºãïœâããã«åºåã¯ããã·ã«åºã§
ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé é èšèŒã®ååç©ã®
C1âC6ã¢ã«ãã«ãšã¹ãã«ã ïŒ åŒïŒïŒïŒ åŒäžãR1ã¯æ°ŽçŽ åååã¯ãåŒãåºïŒäœãã R4åã³R5ã¯ãããããç¬ç«ã«C1âC4ã¢ã«ãã«åº
ã§ããïŒã«ãã€ãŠçœ®æãããåã¯çœ®æãããŠããª
ãC1âC6ã¢ã«ãã«åºã§ãããR2ã¯C1âC4ã¢ã«ã
ã«åºã§ãããR3ã¯ããªãžã«åºåã¯ã¡ãã«åºã«ã
ã€ãŠçœ®æãããããªãžã«åºãè¡šããã®çœ®æïŒâ
ã·ã¯ããããã«âã¯ãã¢ã³ãªãã³ã«è£œè¬åŠçã«èª
容æ§ã®ãã®å¡©ã補é ããã«åœããåŒïŒïŒïŒ åŒäžãR1ãR2åã³R3ã¯åèšã®ãã®ãè¡šããã®
ååç©åã¯ãã®å¡©ãã·ã¯ããããã³åããå¿ èŠã«
å¿ããŠãåŒïŒïŒã®ååç©ã補è¬åŠçã«èªå®¹æ§ã®
å¡©ã«å€æããããšãç¹åŸŽãšããã眮æïŒâã·ã¯ã
ãããã«âã¯ãã¢ã³ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®
ãã®å¡©ã®è£œé æ³ã ïŒ åŒïŒïŒïŒ åŒäžãR2ã¯C1âC4ã¢ã«ãã«åºã§ãããR3ã¯ããª
ãžã«åºåã¯ã¡ãã«åºã«ãã€ãŠçœ®æãããããªãžã«
åºãè¡šããã®çœ®æïŒâã·ã¯ããããã«âã¯ãã¢
ã³ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãã®å¡©ã補é ãã
ã«åœããåŒïŒïŒïŒ åŒäžãR1ã¯ãåŒãåºïŒããã§R4åã³R5ã¯ã ã¯ããããç¬ç«ã«C1âC4âã¢ã«ãã«åºã§ããïŒ
ã«ãã€ãŠçœ®æããããåã¯çœ®æãããŠããªãC1
âC6âã¢ã«ãã«åºã§ãããR2åã³R3ã¯åèšã®ã
ã®ãè¡šããã®ååç©åã¯ãã®å¡©ãã·ã¯ãããã
ã³åããå ¬ç¥æ¹æ³ã§å æ°Žå解ããå¿ èŠã«å¿ããŠã
åŒïŒïŒã®ååç©ã補è¬åŠçã«èªå®¹æ§ã®å¡©ã«å€æ
ããããšãç¹åŸŽãšããã眮æïŒâã·ã¯ããããã«
âã¯ãã¢ã³ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãã®å¡©ã®
補é æ³ã ïŒ åŒïŒïŒïŒ ããããã
åŒäžãR1ã¯ãåŒãåºïŒäœããR4åã³R5ã¯ã ãããç¬ç«ã«C1âC4ã¢ã«ãã«åºã§ããïŒã«ãã€
ãŠçœ®æãããåã¯çœ®æãããŠããªãC1âC6ã¢ã«
ãã«åºã§ãããR2ã¯C1âC4ã¢ã«ãã«åºã§ããã
R3ã¯ããªãžã«åºåã¯ã¡ãã«åºã«ãã€ãŠçœ®æãã
ãããªãžã«åºãè¡šããã®çœ®æïŒâã·ã¯ãããã
ã«âã¯ãã¢ã³ãªãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãã®å¡©
ã補é ããã«åœããåŒïŒïŒïŒ åŒäžãR1ãR2åã³R3ã¯åèšã®ãã®ãè¡šããã®
ååç©åã¯ãã®å¡©ãã·ã¯ããããã³åããå ¬ç¥æ¹
æ³ã§ãšã¹ãã«åããå¿ èŠã«å¿ããŠãåŒïŒïŒã®å
åç©ã補è¬åŠçã«èªå®¹æ§ã®å¡©ã«å€æããããšãç¹
城ãšããã眮æïŒâã·ã¯ããããã«âã¯ãã¢ã³ãª
ãã³ã«è£œè¬åŠçã«èªå®¹æ§ã®ãã®å¡©ã®è£œæ³ã ïŒïŒ åŒïŒïŒïŒ åŒäžãR1ã¯æ°ŽçŽ ååã§ãããåã¯ãåŒãåº ïŒäœããR4åã³R5ã¯ãããããç¬ç«ã«C1âC4ã¢ã«
ãã«åºã§ããïŒã«ãã€ãŠçœ®æããããåã¯çœ®æã
ããŠããªãC1âC6ã¢ã«ãã«åºã§ãããR2ã¯C1â
C4ã¢ã«ãã«åºã§ãããR3ã¯ããªãžã«åºåã¯ã¡ã
ã«åºã«ãã€ãŠçœ®æãããããªãžã«åºãè¡šããã®
眮æïŒâã·ã¯ããããã«âã¯ãã¢ã³ãªãã³ã«è£œè¬
åŠçã«èªå®¹æ§ã®ãã®å¡©åã³è£œè¬åŠçã«èªå®¹æ§ã®æ
æå€åã³ïŒåã¯åžéå€ãå«æããããšãç¹åŸŽãšã
ããæã¢ã¬ã«ã®ãŒå€ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT26399/77A IT1093451B (it) | 1977-08-02 | 1977-08-02 | It2-ciclopropil-cromoni sostituiti |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5726682A JPS5726682A (en) | 1982-02-12 |
JPS6222992B2 true JPS6222992B2 (ja) | 1987-05-20 |
Family
ID=11219402
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9541981A Granted JPS5726683A (en) | 1977-08-02 | 1981-06-22 | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition |
JP9541781A Granted JPS5726681A (en) | 1977-08-02 | 1981-06-22 | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition |
JP9541881A Granted JPS5726682A (en) | 1977-08-02 | 1981-06-22 | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9541981A Granted JPS5726683A (en) | 1977-08-02 | 1981-06-22 | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition |
JP9541781A Granted JPS5726681A (en) | 1977-08-02 | 1981-06-22 | Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition |
Country Status (6)
Country | Link |
---|---|
JP (3) | JPS5726683A (ja) |
AU (1) | AU515770B2 (ja) |
BE (1) | BE869407A (ja) |
IT (1) | IT1093451B (ja) |
SU (1) | SU957766A3 (ja) |
ZA (1) | ZA784023B (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0390889U (ja) * | 1989-12-29 | 1991-09-17 | ||
JPH0390892U (ja) * | 1989-12-29 | 1991-09-17 | ||
JPH03117696U (ja) * | 1989-12-19 | 1991-12-05 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62108276U (ja) * | 1985-12-25 | 1987-07-10 | ||
JPS6455214U (ja) * | 1987-10-01 | 1989-04-05 | ||
CN101720390A (zh) * | 2008-06-10 | 2010-06-02 | äžè±éå·¥äžæ ªåŒäŒç€Ÿ | é£ååçµè£ 眮åå ¶å»ºè®Ÿæ¹æ³ |
-
1977
- 1977-08-02 IT IT26399/77A patent/IT1093451B/it active
-
1978
- 1978-07-10 AU AU37891/78A patent/AU515770B2/en not_active Expired
- 1978-07-14 ZA ZA00784023A patent/ZA784023B/xx unknown
- 1978-07-31 BE BE189616A patent/BE869407A/xx not_active IP Right Cessation
-
1979
- 1979-10-15 SU SU792835389A patent/SU957766A3/ru active
-
1981
- 1981-06-22 JP JP9541981A patent/JPS5726683A/ja active Granted
- 1981-06-22 JP JP9541781A patent/JPS5726681A/ja active Granted
- 1981-06-22 JP JP9541881A patent/JPS5726682A/ja active Granted
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03117696U (ja) * | 1989-12-19 | 1991-12-05 | ||
JPH0390889U (ja) * | 1989-12-29 | 1991-09-17 | ||
JPH0390892U (ja) * | 1989-12-29 | 1991-09-17 |
Also Published As
Publication number | Publication date |
---|---|
JPS5726682A (en) | 1982-02-12 |
JPS5726681A (en) | 1982-02-12 |
IT1093451B (it) | 1985-07-19 |
AU515770B2 (en) | 1981-04-30 |
ZA784023B (en) | 1979-07-25 |
JPS5726683A (en) | 1982-02-12 |
BE869407A (fr) | 1978-11-16 |
JPS6222989B2 (ja) | 1987-05-20 |
AU3789178A (en) | 1980-01-17 |
JPS6222993B2 (ja) | 1987-05-20 |
SU957766A3 (ru) | 1982-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ187334A (en) | Dextro isomers of asymmetric spiro-hydantoins for treatment of diabetes-associated complications | |
JPH0568476B2 (ja) | ||
EP0350878B1 (en) | Conjugated gamma-oxybutenolide compounds for treating ulcer | |
JPS6222992B2 (ja) | ||
JPH01151570A (ja) | ã¯ããã³èªå°äœããã®è£œé æ³ãåã³ãã®å»è¬ã§ã®äœ¿çš | |
EP0190298B1 (en) | 4-(isoxazolyl)-thiazole-2-oxamic acids and derivatives thereof | |
US4406908A (en) | Tetrazolylcoumarin derivatives and antiallergic compositions containing the same | |
SU858570A3 (ru) | СпПÑПб пПлÑÑеМО пÑПОзвПЎМÑÑ 3-/ÑеÑÑазПл-5-Ол/-1-азакÑаМÑПМа ОлО ÐžÑ ÑПлей | |
US4252818A (en) | Novel benzopyran derivatives | |
US4157334A (en) | 6-Carboxy-flavone derivatives and process for their preparation | |
US4160028A (en) | Substituted 2-cyclopropyl-chromones and pharmaceutical compositions and use thereof | |
JPS5930711B2 (ja) | 眮æïŒâããã«âã¯ãã¢ã³ããã®è£œæ³åã³ãã®ååç©ãå«æããæã¢ã¬ã«ã®âäœçšãæããå»è¬çµæç© | |
CA1154772A (en) | Substituted 2-(pyridyl-cyclopropyl)-chromones and process for their preparation | |
JP2790335B2 (ja) | å ±åœ¹Î³âãªãã·ãããã©ã€ãååç©ããã³ãããæå¹æåãšããæ朰çå€ | |
JPS6121636B2 (ja) | ||
US5292751A (en) | 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-(1-propyl))piperidinyl)-4H-1-benzopyran-4-one, its preparation and its use | |
JPS60142968A (ja) | æ°èŠãžã¢ãžã³âãšããã«ããšãã«ãªããµãã³é ž | |
GB2061261A (en) | Substituted 2-(pyridylcyclopropyl)-chromones | |
KR820000122B1 (ko) | ì¹íë 2-ë¹ë-í¬ë¡ëª¬ì ì ì¡°ë°©ë² | |
KR890004662B1 (ko) | 1,8-ëíí°ëŠ¬ë곌 1,5,8-ììëíí°ëŠ¬ë ì ë첎 ë° ìŽì ì ì¡°ë°©ë² | |
GB2055797A (en) | 2-[(Trimethoxy-phenyl)-cyclopropyl]-chromone derivatives and process for their preparation | |
KR890002638B1 (ko) | 4H-벀조 [4, 5] ì¬ìŽíŽë¡íµí [1, 2-b] í°ì€í ì ë첎ì ì ì¡°ë°©ë² | |
KR820000370B1 (ko) | ì¹íë 2-ì¬ìŽíŽë¡íë¡í-í¬ë¡ëª¬ì ì ì¡°ë°©ë² | |
JPS6026794B2 (ja) | ïŒâã¢ããã¯ãã¢ã³âïŒâã«ã«ãããµã¢ã«ãããèªå°äœããã³ãã®è£œé æ³ | |
US3949091A (en) | 8-Substituted dibenzobicyclo[3.2.1]octadienes for treating depression |